![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Leo Pharma A/s Ballerup Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Heparin sodium, For parenteral preparations, European and Chilean origin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-446 - Rev 03
This Chemical Type CEP, issued on February 21, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 333 associated with this CEP further emphasizes